Islet engages OraSure board. OraSure Technologies stock gains 1.80 percent
Published on 10/08/2026 at 22:06 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWSKey points in brief
- Islet Management engaged OraSure Technologies on September 17, 2026 over potential board changes involving one or more directors.
- OraSure reported USD 30.6 million in second-quarter 2026 revenue and a 43.5 percent GAAP gross margin.
- The stock was at EUR 3.40 at Lang & Schwarz on October 8, 2026, up 1.80 percent from EUR 3.34.
- OraSure's next scheduled earnings report is November 4, 2026, after the market closes.
OraSure Technologies (ISIN US68554V1089) was trading at EUR 3.40 at Lang & Schwarz on October 8, 2026 at 10:03 p.m. CEST, plus 1.80 percent versus the prior close of EUR 3.34. On September 17, 2026, Islet Management said it had engaged with OraSure's board and management about shareholder value and potential changes including one or more additional directors, according to MarketScreener.
Three milestones shape the story
On July 21, 2026, OraSure received emergency use authorization for its second-generation OraQuick Ebola 2.0 rapid antigen test, which detects four Ebola virus species, according to OraSure Technologies. On August 5, 2026, the company reported USD 30.6 million of revenue for the second quarter and a 43.5 percent GAAP gross margin, according to Yahoo Finance. On September 17, 2026, Islet's proposal involved potential changes to the board, including one or more directors, according to MarketScreener.
What does the earnings profile show?
The second-quarter revenue figure was 9.70 percent higher than the first quarter's USD 27.93 million, while net income moved from a USD 23.27 million loss to USD 6.76 million of profit. The quarterly call also set third-quarter revenue guidance at USD 29.5 million to USD 32.5 million and said gross margin should remain similar to the second-quarter level, according to Yahoo Finance.
Next date is November 4
OraSure is scheduled to report third-quarter 2026 results on November 4, 2026, after the market closes, with the conference call listed for 5:00 p.m. ET by MarketBeat. That report will test whether the USD 29.5 million to USD 32.5 million guidance range can offset the board-related uncertainty around the stock.
Stock trades after a positive session
At Lang & Schwarz, OraSure Technologies was trading at EUR 3.40 on October 8, 2026 at 10:03 p.m. CEST, up 1.80 percent from the EUR 3.34 prior close. The primary listing is Nasdaq in USD, and the latest structured quote showed a market capitalization of USD 261.3 million and a 52-week range of USD 2.08 to USD 4.58 as of October 8, 2026. The further course of trading is shown by the continuously updated real-time quote of OraSure Technologies stock.
OraSure Technologies stock facts
- Company: OraSure Technologies, Inc.
- ISIN: US68554V1089
- WKN: 881351
- Ticker: OSUR
- Primary exchange: NASDAQ
- Price Lang & Schwarz (as of October 8, 2026, 10:03 p.m. CEST): EUR 3.40
- Change versus prior close: plus 1.80 percent
- Prior close Lang & Schwarz (October 7, 2026): EUR 3.34
- Market capitalization: USD 261.3 million (as of October 8, 2026)
- 52-week range: USD 2.08-4.58 (as of October 8, 2026)
- Sector / Industry: Health Care / Medical Equipment, Supplies and Distribution
- Index membership: NASDAQ Composite
- Next earnings date: November 4, 2026
Market context: Market report S&P 500.
